Showing results (471-480 of 540) with videos related to
Sort By:
Pageof 54
Cellular and Molecular Gastroenterology and Hepatology|May 3, 2017
Cell Adhesion Molecule CD166/ALCAM Functions Within the Crypt to Orchestrate Murine Intestinal Stem Cell HomeostasisNicholas R Smith, Paige S Davies, Trevor G Levin, et al.Journal of Clinical Microbiology|August 14, 2015
Performance of the CLSI Carba NP and the Rosco Carb Screen Assays Using North American Carbapenemase-Producing Enterobacteriaceae and Pseudomonas aeruginosa IsolatesLauren C Gallagher, Sylvester S Roundtree, Diana P Lancaster, et al.Journal of Vascular Surgery|December 31, 1997
Presentation and management of venous aneurysmsD L Gillespie, J L Villavicencio, C Gallagher, et al.Annals of Translational Medicine|April 6, 2016
Chest CT abnormalities and quality of life: relationship in adult cystic fibrosisAoife Kilcoyne, Lisa P Lavelle, Colin J McCarthy, et al.Gynecologic Oncology|April 29, 2006
Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First StudyC B Steer, K Chrystal, K A Cheong, et al.Gut|November 16, 2004
Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutationN J H Sturt, M C Gallagher, P Bassett, et al.Toxicology and Applied Pharmacology|May 29, 2002
Automated in vitro screening of teratogensPeter S Walmod, Anton Berezin, Helen C Gallagher, et al.Biochimica Et Biophysica Acta|February 18, 2004
pH gradient loading of anthracyclines into cholesterol-free liposomes: enhancing drug loading rates through use of ethanolNancy Dos Santos, Kelly A Cox, Cheryl A McKenzie, et al.Cancer Chemotherapy and Pharmacology|January 1, 1986
A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervixR E Coleman, P G Harper, C Gallagher, et al.American Journal of Obstetrics and Gynecology|July 20, 1999
Efficacy and safety of low, standard, and high dosages of an estradiol transdermal system (Esclim) compared with placebo on vasomotor symptoms in highly symptomatic menopausal patients. The Esclim Study GroupW H Utian, K A Burry, D F Archer, et al.Pageof 54